TONIX PHARMACEUTICALS HLDG C
Q4 2025 13F Holders
Symbol
TNXP
CUSIP
890260839
Type
Equity
Class
COM NEW
Num filings
76
Total reported value, excl. options
$58.5 M
Compare 2025 Q4 to
2026 Q3
2026 Q2
2026 Q1
2025 Q3
2025 Q2
2025 Q1
2024 Q4
Manager
Report Date
Value ($000)
Shares
Option Type